Products - Chronic obstructive pulmonary disease | Topic | NICE

Showing 3 products

Date | Title

Status: In developmentRemove ‘Status: In development’ filter

Mepolizumab for maintenance treatment of uncontrolled chronic obstructive pulmonary disease with raised blood eosinophils [ID1237]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
6 August 2026
Astegolimab as add-on maintenance treatment for moderate to severe chronic obstructive pulmonary disease [ID6524]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Benralizumab to reduce exacerbations in moderate to very severe chronic obstructive pulmonary disease [ID1394]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC